Net sales revenues were also down 4.1% to 3 mln leva from 3.2 mln leva in the same period of 2006. Most of the sales went to Sopharma AD. Financial revenues decreased from 720,000 leva to 79,000 leva.
Meanwhile economic elements costs grew 16% to 2.82 mln leva from 2.44 mln leva a year ago. Financial costs went down from 329,000 leva to 115,000 leva.
Bulgarska Roza-Sevtopolis has a core capital of 6.033 mln leva. Its own capital amounts to 10.58 mln leva. The company will hold a general shareholders’ meeting on 28 June 2007, which is expected to vote a proposal to increase its capital via the issuance of new shares from 6,032,712 leva to 12,065,424 leva.
Sopharma AD controls 49.00% of the company’s capital, Telso AD holds 6.6%.
Bulgarska Roza-Sevtopolis is a producer and trader of essential oils, perfumery and cosmetics, substances and drugs.
Shares of Bulgarska Roza-Sevtopolis lost 1.29% to 6.11 leva/shares yesterday.